The Arcturus subvariant stems from the Omicron strain of Covid-19 and is known as XBB.1.16 since it descends from the recombinant variant XBB, which combines two sublineages of Omicron BA.2.

The COVID-19 variant, Arcturus, is a sub-variant of Omicron, also known as the XBB.1.16 strain, and has been found in 22 countries, including Singapore, Australia, the UK, and the US. Since March ...

The first recorded death of someone who has the new Arcturus strain of Covid-19 has been revealed. This variant has been described as the most transmissible yet and has a symptom which has not ...

A 'zombie star' could be resurrected on Halloween night, experts say. T Coronae Borealis, also known as the 'Blaze Star,' is expected to explode, which will illuminate a dead binary star system.

the MHLW is an important milestone for the saRNA field and the Arcturus/CSL alliance, which has candidates against other variants in phase 3 testing – including the prevailing XBB.1.5 strain ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Arcturus Therapeutics ARCT in the last three months. The table below summarizes their recent ...

Neda Safarzadeh, Sr. Director, Head of IR, PR & Marketing, Arcturus Therapeutics Holdings Inc., San Diego, CA, USA, Tel: +1-858-900-2682 Arcturus Therapeutics, based ...

The ongoing Phase 1 study, fully funded by BARDA, aims to evaluate the safety and immune responses of the vaccine, reducing financial strain on Arcturus’ other therapeutic programs. Additionally ...

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant ...

Arcturus is advancing its vaccine and rare disease pipeline with significant developments. The initiation of a BARDA-funded Phase 1 study for bird flu, along with ongoing studies in cystic ...